Allocation concealment appraisal of clinical therapy trials using the extended Composite Quality Score (CQS-2): An empirically based update (Protocol)

doi:10.21203/rs.3.rs-2520122/v1

Download PDF

Method Article

Allocation concealment appraisal of clinical therapy trials using the extended Composite Quality Score (CQS-2): An empirically based update (Protocol)

https://doi.org/10.21203/rs.3.rs-2520122/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

Objectives: To revise CQS-2/Criterion II, concerning allocation concealment appraisal for prospective, controlled, clinical therapy trials.

Methods: Meta-analyses of trials with inadequate allocation concealment will be tested for in-between trial heterogeneity (I² > 0) due to imbalances in baseline variables. Meta-analyses with positive test results will be used as basis to infer criteria for adequate allocation concealment. The CQS-2/Criterion II will be reformulated in line with the findings. The revised appraisal tool will be specified as CQS-2B

Reporting: The final report will be made available online as preprint in one of the major preprint repositories and submitted to a peer-reviewed journal.

Internal Medicine

Composite Quality Score

trial appraisal

clinical trials

allocation concealment

selection bias

Download PDF

Version 1

posted

You are reading this latest preprint version

Allocation concealment appraisal of clinical therapy trials using the extended Composite Quality Score (CQS-2): An empirically based update (Protocol)

Status:

Version 1

Abstract

Full Text

Status:

Version 1